Guardant Health annual return on equity
2018
2019
2020
2021
2022
2023
2024
Guardant Health Return on Equity (ROE) Growth & History (GH)
Guardant Health's return on equity was −4,584.47% for fiscal 2024.
View full Guardant Health company overviewGuardant Health annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −4,584.47% | −4146.35 pp |
| 2023 | 2023-12-31 | −438.13% | −252.48 pp |
| 2022 | 2022-12-31 | −185.65% | −146.05 pp |
| 2021 | 2021-12-31 | −39.60% | −16.11 pp |
| 2020 | 2020-12-31 | −23.49% | −11.68 pp |
| 2019 | 2019-12-31 | −11.81% | +9.68 pp |
| 2018 | 2018-12-31 | −21.49% | — |
Guardant Health quarterly return on equity
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-06-30 | −307.86% | −249.21 pp |
| Q1 2024 | 2024-03-31 | −101.32% | +1607.46 pp |
| Q4 2023 | 2023-12-31 | −96.67% | +26.66 pp |
| Q3 2023 | 2023-09-30 | −33.05% | +33.64 pp |
| Q2 2023 | 2023-06-30 | −58.64% | −4.80 pp |
| Q1 2023 | 2023-03-31 | −1,708.78% | −1687.86 pp |
| Q4 2022 | 2022-12-31 | −123.33% | −112.65 pp |
| Q3 2022 | 2022-09-30 | −66.69% | −52.33 pp |
| Q2 2022 | 2022-06-30 | −53.85% | −41.91 pp |
| Q1 2022 | 2022-03-31 | −20.92% | −10.91 pp |
| Q4 2021 | 2021-12-31 | −10.68% | −2.89 pp |
| Q3 2021 | 2021-09-30 | −14.36% | −7.87 pp |
| Q2 2021 | 2021-06-30 | −11.93% | −6.70 pp |
| Q1 2021 | 2021-03-31 | −10.01% | −5.99 pp |
| Q4 2020 | 2020-12-31 | −7.78% | −4.08 pp |
| Q3 2020 | 2020-09-30 | −6.50% | −4.89 pp |
| Q2 2020 | 2020-06-30 | −5.24% | −3.48 pp |
| Q1 2020 | 2020-03-31 | −4.02% | +0.47 pp |
| Q4 2019 | 2019-12-31 | −3.71% | +3.10 pp |
| Q3 2019 | 2019-09-30 | −1.61% | +7.07 pp |
| Q2 2019 | 2019-06-30 | −1.76% | — |
| Q1 2019 | 2019-03-31 | −4.49% | — |
| Q4 2018 | 2018-12-31 | −6.81% | — |
| Q3 2018 | 2018-09-30 | −8.68% | — |
Guardant Health return on equity trends
Over the last five fiscal years, Guardant Health's return on equity decreased from −11.81% to −4,584.47%, a change of −4572.67 percentage points. The latest reported quarter, Q2 2024, shows −307.86%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Guardant Health source filings ↗